-
公开(公告)号:US11878975B2
公开(公告)日:2024-01-23
申请号:US16955097
申请日:2018-12-18
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , John L. Gilmore , Tasir Shamsul Haque , Trevor C. Sherwood , Brian K. Whiteley , Shoshana L. Posy , Sreekantha Ratna Kumar , Laxman Pasunoori , Srinivasan Kunchithapatham Duraisamy , Subramanya Hegde , Rushith Kumar Anumula , Pitani Veera Venkata Srinivas
IPC分类号: C07D471/08 , C07D487/08 , C07D519/00 , C07D471/04 , C07D401/04 , C07D401/10 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D453/02 , C07D487/04 , C07D491/08
CPC分类号: C07D471/04 , C07D401/04 , C07D401/10 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D453/02 , C07D487/04 , C07D491/08
摘要: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US11447466B2
公开(公告)日:2022-09-20
申请号:US16635593
申请日:2018-08-03
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Brian K. Whiteley , John L. Gilmore
IPC分类号: A61K31/4545 , A61P29/00 , A61P37/00 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14
摘要: Disclosed are compounds of Formula (I) or a salt thereof, wherein: Y is Formula (II), or Formula (III); R1, R2, R2a, R2b, R2c, R3, R4, R5, m, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20200038374A1
公开(公告)日:2020-02-06
申请号:US16653297
申请日:2019-10-15
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Shoshana L. Posy , Ramesh Kumar Sistla , Subramanya Hegde , Anupama Kandhi Ramachandra Reddy
IPC分类号: A61K31/4196 , C07D249/00 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D471/04
摘要: Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US11672780B2
公开(公告)日:2023-06-13
申请号:US17113495
申请日:2020-12-07
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Shoshana L. Posy , Ramesh Kumar Sistla , Subramanya Hegde , Anupama Kandhi Ramachandra Reddy
IPC分类号: A61K31/4196 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D471/04 , C07D249/00
CPC分类号: A61K31/4196 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D249/00 , C07D471/04
摘要: Disclosed are compounds of Formula (I)
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.-
公开(公告)号:US10660877B2
公开(公告)日:2020-05-26
申请号:US16330964
申请日:2017-09-08
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Michael A. Poss , Sreekantha Ratna Kumar , Shoshana L. Posy , David R. Tortolani , Brian K. Whiteley , Ramesh Kumar Sistla , Subramanya Hegde , Anupama Kandhi Ramachandra Reddy
IPC分类号: A61K31/404 , A61P37/06 , A61P29/00 , A61K9/00 , C07D401/14
摘要: Disclosed are compounds of Formula (I) N-oxide, or salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20210253593A1
公开(公告)日:2021-08-19
申请号:US16763670
申请日:2018-11-13
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Trevor C. Sherwood , John L. Gilmore , Tasir Shamsul Haque , Brian K. Whiteley , David R. Tortolani , Shoshana L. Posy , John E. Macor , Louis J. Lombardo , Ramesh Kumar Sistla , Anupama Kandhi Ramachandra Reddy , Subramanya Hegde , Laxman Pasunoori , Sreekantha Ratna Kumar
IPC分类号: C07D498/04 , C07D413/14 , C07D471/04 , C07D487/04 , C07D417/14 , C07D405/14 , C07D513/04 , C07D401/14 , C07D495/04
摘要: Disclosed are compounds of Formula (I) or salts thereof, wherein Ring Het, R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20210085651A1
公开(公告)日:2021-03-25
申请号:US17113495
申请日:2020-12-07
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Shoshana L. Posy , Ramesh Kumar Sistla , Subramanya Hegde , Anupama Kandhi Ramachandra Reddy
IPC分类号: A61K31/4196 , C07D249/00 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D471/04
摘要: Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20200339581A1
公开(公告)日:2020-10-29
申请号:US16955166
申请日:2018-12-19
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , David R. Tortolani , Tasir Shamsul Haque , Shoshana L. Posy
IPC分类号: C07D471/10 , C07D401/14 , C07D403/04 , C07D471/04 , C07D209/12 , C07D413/12 , C07D409/14
摘要: Disclosed are compounds of Formula (I) or salts thereof, wherein G, R1, R5, R7, R8, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20200331920A1
公开(公告)日:2020-10-22
申请号:US16954543
申请日:2018-12-18
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Trevor C. Sherwood , Tasir Shamsul Haque , Shoshana L. Posy , Sreekantha Ratna Kumar , Laxman Pasunoori , Subramanya Hegde , Rushith Kumar Anumula
IPC分类号: C07D487/04 , C07D403/10 , C07D491/08 , C07D209/42 , C07D405/14 , C07D401/12 , C07D417/14 , C07D401/14 , C07D401/10 , C07D417/12 , C07D403/14
摘要: N-oxides, or salts thereof, wherein G, L2, R1, R5, R9, R10, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmunediseases.
-
公开(公告)号:US20200239437A1
公开(公告)日:2020-07-30
申请号:US16635593
申请日:2018-08-03
发明人: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Brian K. Whiteley , John L. Gilmore
IPC分类号: C07D401/14 , C07D405/14 , C07D409/14
摘要: Disclosed are compounds of Formula (I) or a salt thereof, wherein: Y is Formula (II), or Formula (III); R1, R2, R2a, R2b, R2c, R3, R4, R5, m, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
-
-
-
-
-
-
-
-